Mahana Therapeutics
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
230 California St Ste 302, San Francisco...Phone Number
(518) 569-1549Website
www.mahanatx.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Mahana Therapeutics
Mahana Therapeutics is the global leader in prescription digital therapeutics for gastrointestinal conditions. Parallel, Mahana's debut product, is the first digital therapeutic authorized for marketing by the U.S. FDA to reduce the severity of symptoms of irritable bowel syndrome (IBS), a condition that affects one in 10 people worldwide. Guided by a commitment to rigorous clinical evidence and drawn from experience as patients ourselves, Mahana's team of experienced entrepreneurs, physicians, psychologists, engineers, and designers are dedicated to using software to treat and manage chronic conditions that affect so many. Founded in 2018, Mahana is located in San Francisco and London.Explore more
Mahana Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mahana Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Mahana Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mahana Therapeutics
Funding: Get notified immidiatlly once Mahana Therapeutics has new funding data
Check if Mahana Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mahana Therapeutics had a recent Job posting/layoffs
Check out if Mahana Therapeutics is spiking on competitors!
Earning: See what the market has to say on Mahana Therapeutics recently announced quarterly report
Product Launch: Get notified when Mahana Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Mahana Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Mahana Therapeutics
Compare insights from companies similar to Mahana Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mahana Therapeutics
$5.4M
11-50
Private
$70.4M
2018
JW
Jon WilsonRegional Manager, Engagement Mahana Tinnitus
Company Profile Activity
Activity Insights
Mahana Therapeutics is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Mahana Therapeutics is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Mahana Therapeutics.
Mahana Therapeutics financials insights
Gather financial insights about Mahana Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$9.4M
2021
Series B
$61M
Mahana Therapeutics Tech Stack
A closer look at the technologies used by Mahana Therapeutics
Mahana Therapeutics News & Media
Mahana Therapeutics Appoints Justin Zamirowski, Jr. as Chief Commercial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Mahana Therapeutics, a leading developer of digital therapeutics, has appointed Justin Zamirowski, Jr. as chief commercial officerWorld IBS Day - April 19th: The IBS Experience for IBS Sufferers
Patient creative pictures, prose and poetry to be shared on #WorldIBSDay April 19th to raise awareness about the quality of life issues while living with Irritable Bowel Syndrome (PRWeb March 17, 2022) Read the full story at https://www.prweb.com/releases/world_ibs_day_april_19th_the_ibs_experience_for_ibs_sufferers/prweb18561201.htmMahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program
LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Mahana Therapeutics has been selected to DigitalHealth.London's Accelerator programme, which identifies digital solutions that can meet NHS challengesMahana Therapeutics Secures $61 Million Series B Financing to Support Commercialization and Further Development of Digital Therapeutics
SAN FRANCISCO--(BUSINESS WIRE)-- #IBS--Mahana Therapeutics, a leading developer of prescription digital therapeutics designed to empower patients with chronic health conditions, has completed a $61 million Series B financing. The company will use the funds to launch the FDA-cleared prescription digital therapeutic Mahana™ IBS and accelerate development of several digital therapeutics for chronic health conditions. JAZZ Venture Partners and Gurnet Point Capital led the financing with significant
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mahana Therapeutics
Sign Up For FreeTo access detailed company insights
Mahana Therapeutics is the global leader in prescription digital therapeutics for gastrointestinal conditions. Parallel, Mahana's debut product, is the first digital therapeutic authorized for marketing by the U.S. FDA to reduce the severity of symptoms of irritable bowel syndrome (IBS), a condition that affects one in 10 people worldwide. Guided b... Read More
